QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: How to Read and Cite EU Pharmaceutical Legislation

Test your understanding of the concepts covered by How to Read and Cite EU Pharmaceutical Legislation: Regulations, Directives, Decisions and Guidance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A regulatory statement says, 'EMA requires this.' Why is that citation normally inadequate?

EMA never issues regulatory documents Institutional attribution identifies the speaker but not the exact document, version, provision or authority Only national authorities may issue guidance A statement can never be supported by an agency document

Question 2 of 10 An implementing act is being assessed. Which question is most important for establishing its authority?

Which search engine first indexed it? Which scientific committee discussed it? What enabling legislation grants the implementing power and what uniform conditions does the act establish? Whether it appears in a commercial regulatory database

Question 3 of 10 A current compliance assessment is being prepared using a consolidated directive. What should the assessor verify before relying on it?

Only the document's file format That the consolidated version reflects the law applicable to the current question and that relevant amendments and transitional rules have been considered That no original Official Journal act exists That the directive has been converted into a regulation

Question 4 of 10 Why should a reader not determine the legal status of an EU act solely from the word used in its title, such as regulation or decision?

Titles are never legally relevant The same type of instrument can perform different functions and may be legislative, delegated or implementing depending on its legal basis and adoption procedure All EU acts have identical legal effects Only guidance documents have a legal basis

Question 5 of 10 Which statement most accurately distinguishes an EMA committee opinion from a Commission decision?

They are always legally identical A committee opinion may be an important procedural or scientific stage, but it should not automatically be presented as the final legally operative decision A Commission decision is always non-binding A committee opinion can never have procedural consequences

Question 6 of 10 A pharmacovigilance committee concludes that new evidence changes the benefit-risk balance. Which statement best describes the relationship between that conclusion and a legal obligation?

The scientific conclusion is automatically the final legal obligation Scientific evidence may lead to assessment and regulatory procedures, but the legally operative consequence depends on the applicable legal act or decision Scientific conclusions have no relevance to regulatory action The conclusion automatically amends the relevant directive

Question 7 of 10 Why should a regulatory professional follow necessary cross-references instead of stopping at the first relevant article?

Cross-references are included only for historical interest Another provision, annex or related act may define the condition, exception, procedure or technical detail needed to interpret the obligation The first article in an act is never operative Cross-references convert guidance into legislation

Question 8 of 10 Why are entry into force and date of application treated as separate concepts?

They are always identical under EU law An act may enter into force on one date while substantive provisions apply later, subject to transitional arrangements Entry into force applies only to guidance The date of application is relevant only for national legislation

Question 9 of 10 Which information is most important in a source record for a high-consequence regulatory assessment?

Only the name of the person who found the document Source title, issuing authority, identifier, version or publication date, retrieval date, applicable date and relevant provision Only the webpage URL Only a summary of the conclusion

Question 10 of 10 A referral occurred in 2018, but the relevant legal provision was substantially amended in 2023. Which source approach is most appropriate for reconstructing the historical legal position?

Use only the current consolidated text Use the legal version applicable in 2018, including relevant original provisions, amendments and transitional rules Use the most recent guidance regardless of its date Use the date on which the issue was discovered rather than the date of the regulatory event

QPPV.com

Knowledge Assessment: How to Read and Cite EU Pharmaceutical Legislation

Cookie Settings